ClinicalTrials.gg
RecruitingNCT07230262ACRO-IBDUpdated Nov 17, 2025

Trial Comparing Multiport RObotic and Laparoscopic Surgery for Elective Colorectal Resections in IBD Patients (ACRO-IBD)

An interventional study of Robotic colorectal surgery and Laparoscopic colorectal surgery in IBD - Inflammatory Bowel Disease, sponsored by Universitaire Ziekenhuizen KU Leuven. Recruiting at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-11-17.

Sponsored by Universitaire Ziekenhuizen KU Leuven · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 61 studies in Inflammatory Bowel Diseases with a site in Belgium — 13 open to participants now, 18 under way, 5 of them phase 3. Inflammatory Bowel Diseases · Belgium.

Planned enrollment
33rd of 50
110 · median 144
Started
2025
with 4 others
No phase
6 of 61
4 open now
Primary completion
2028-05
later than 15 of 17 live
Registered
59th of 61
by date
Lead sponsor
6 of 61
Universitaire Ziekenhuizen KU Leuven

Among the 61 studies in Inflammatory Bowel Diseases with a site in Belgium, this one is the 33rd largest by planned enrollment of the 50 interventional ones that give a count, is one of 5 that started in 2025, is one of 6 with no phase, reaches primary completion later than 15 of the 17 other live ones, and was the 59th registered.

Inflammatory Bowel Diseases

1,555 studies on the registry are indexed under Inflammatory Bowel Diseases; 425 are open to participants now.

Browse Inflammatory Bowel Diseases studies →

Open to participants now

13 of the 61 studies in Inflammatory Bowel Diseases with a site in Belgium are open now. Recruiting first, the newest first:

7 more — sign in →

All 13 open studies →

A study can be open while its sites in Belgium have not opened yet or have stopped. Only those recruiting at a site in Belgium →

Who these studies take

Of the 276 Inflammatory Bowel Diseases studies recruiting now, 134 (49%) set no upper age limit and 114 (41%) stop at 75 or younger; 75 take children under 18; 60 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 61 studies in Inflammatory Bowel Diseases with a site in Belgium, or all of them as a file.
02

Study summary

The aim of this study is to better understand whether robotic surgery leads to better outcomes than laparoscopy in terms of complications, recovery and quality of life.

Read the detailed description

This clinical trial compares two surgical techniques, robotic surgery and conventional laparoscopic surgery, for patients with inflammatory bowel disease (IBD) requiring elective colorectal surgery. Both approaches are minimally invasive and commonly used in clinical practice. This is a randomized trial: participants will be randomly assigned to one of the two techniques. A total of 110 patients will be enrolled.

This study will evaluate the role of robotic surgery in the surgical treatment of inflammatory bowel disease.

Three quality-of-life questionnaires will be completed: before the procedure and at 30 and 90 days post-procedure. Pain will also be assessed during the first three days post-procedure using a specific score called the VAS.

This study will be conducted exclusively at the University Hospitals Leuven.

03

Conditions studied

  • IBD - Inflammatory Bowel Disease

Keywords

  • Patients with inflammatory bowel disease (IBD)
  • Colorectal surgery in IBD patients
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Voluntary written of the participant or their legally authorized representative has been obtained prior to any screening procedures
  2. At least 18 years of age at the time of signing the Informed Consent Form (ICF)
  3. Diagnosed with IBD and eligible for elective minimally invasive colorectal surgery, including:

    1.4 Ileocecal/ileocolic resections 1.5 Segmental colectomies 1.6 Total colectomy 1.7 Proctocolectomy 1.8 Proctectomy

  4. Procedures involving primary anastomosis or temporary or permanent stoma creation
  5. Suitable for minimally invasive surgery

Exclusion criteria

Exclusion Criteria:

  1. Non IBD patients
  2. Urgent surgery (\<24 hours from hospital admission)
  3. Not suitable for minimally invasive surgery
  4. Ileoanal pouch construction
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
110 participants (estimated)

Study arms

  • Active comparator
    multiport RObotic surgery

    Surgical procedure performed using a robotic system.

    Procedure: Robotic colorectal surgery

  • Active comparator
    laparoscopic surgery

    Surgical method that uses a slender camera inserted through small incisions,

    Procedure: Laparoscopic colorectal surgery

Interventions

  • ProcedureRobotic colorectal surgery

    Colorectal surgery using robotic procedure

  • ProcedureLaparoscopic colorectal surgery

    Colorectal surgery using laparoscopic procedure

06

What researchers measure

Primary outcomes

  1. Postoperative morbidity

    Assessed using the Comprehensive Complication Index (CCI)

    Time frame: During the first 90 days postoperatively

Secondary outcomes

  1. Conversion to open surgery

    Robotic/laparoscopic surgery to open surgery

    Time frame: Surgery day

  2. 2. Postoperative pain

    Pain measured according to the visual analogue scale (VAS). The minimum score is 0, the maximum score is 10. The lower the score (e.g. 1 or 2) the less pain; the higher the score (e.g. more than 7) the more pain.

    Time frame: First three postoperative days

  3. Quality of life (QoL)

    QoL using the SF-36 Physical Health Component

    Time frame: At 30 and 90 days postoperatively

  4. Costs

    Direct Medical Costs (Hospital-Based) \& Indirect Hospital Costs

    Time frame: Till 90 days postoperatively

07

Study locations

1 of 1 sites recruiting
  • Abdominal Surgery
    Leuven, Vlaams Brabant 3000, Belgium
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2025 (actual). Primary completion is estimated for May 2028, 31 months after the start.

Of 285 non-industry interventional studies with no phase under Inflammatory Bowel Diseases, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 31 months is above that.

Counting every sponsor, half of 299 studies reached it within 26 months; a quarter within 14 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 16, 2025
First posted
Nov 17, 2025
StartActual
Oct 1, 2025
Primary completionEst.
May 1, 2028
CompletionEst.
Dec 1, 2028
Last update
Nov 17, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07230262
Responsible party
Sponsor
First posted
Nov 17, 2025
Start date
Oct 1, 2025
Primary completion
May 1, 2028 (estimated)
Completion
Dec 1, 2028 (estimated)
Last update
Nov 17, 2025

Study contacts

Isabelle Terrasson
Contact
isabelle.terrasson@uzleuven.be
+3216340837
Brent Cauwberghs, Dr
Contact
brent.cauwberghs@student.kuleuven.be
Gabriele Bislenghi, Professor
principal investigator · UZ Leuven

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion